Chondroradionecrosis of the Larynx: Diagnostic and Therapeutic Measures for Saving the Organ from Radiotherapy Sequelae by Roh, Jong-Lyel
115
INTRODUCTION
Radiotherapy has been shown to be effective in controlling car-
cinoma of the larynx, and the combination of radiotherapy and
an organ-sparing protocol has been used frequently to treat pa-
tients with advanced-staged laryngeal carcinoma. Nevertheless,
irradiation of laryngeal tissue may cause hypoxic, hypovascular,
and hypocellular changes that impair normal collagen synthesis
and cell production, leading to tissue breakdown and the forma-
tion of chronic non-healing wounds (1). The main complications
of radiation therapy for laryngeal carcinoma are laryngeal edema,
skin damage, perichondritis, and cartilage necrosis (2). Patients
with these complications have various clinical manifestations, in-
cluding skin erythema, pain, dysphagia, hoarseness, dyspnea, and
weight loss. In addition, some patients experience laryngeal ed-
ema, ulceration, and cartilage exposure (3).
Chondroradionecrosis (CRN) of the larynx is one of the most
serious complications of radiation therapy. It may progress or
become fatal despite aggressive treatment measures. Hyperbaric
oxygen therapy (HBO) has been used to treat radiation necrosis
of the head and neck (4-7). HBO is thought to repair vascular
beds within the irradiated tissue, enhancing neovascularization
and wound healing. The efficacy of HBO in the treatment of
laryngeal CRN has been described in only a few case reports and
series (6-8). The purpose of this study was to determine the opti-
mal diagnostic methodology and management in six patients with
laryngeal CRN.
Objectives. Chondroradionecrosis (CRN) of the larynx is a rare but fatal complication of radiotherapy. We determined
the optimal diagnostic methodology and management of laryngeal CRN in six patients.
Methods. We retrospectively reviewed the records of six patients with Chandler grade IV laryngeal CRN who had received
prior radiotherapy (mean total radiation dose, 66.7±4.5 Gy) at a tertiary care hospital. Two patients underwent
transoral laser microresection of their laryngeal carcinoma plus postoperative radiotherapy. All patients underwent
endoscopy, computed tomography (CT), positron emission tomography (PET), removal of necrotic tissue, biopsy
under suspension laryngoscopy, administration of antibiotics, and hyperbaric oxygen therapy (HBO). Their diag-
nostic and therapeutic results were assessed.
Results. CT showed CRN of the anterior larynx in three patients and CRN of the posterior larynx in three patients, with
one patient having a false-positive result on PET. HBO consisted of a mean of 36±6 dives. After early debride-
ment and HBO, five patients showed CRN improvement, but one had aggravation and subsequently underwent
total laryngectomy. None of these patients showed local tumor recurrence on pathologic examination or during a
mean follow-up of 24 months.
Conclusion. Although CRN of the larynx may be detected by endoscopic and imaging work-ups, detection may require
pathologic examination. Early debridement and HBO may effectively treat CRN, saving the functional larynx.
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Original ArticleMATERIALS AND METHODS
Patients who presented with CRN of the larynx between 2002
and 2007 at a tertiary care hospital were enrolled in this retro-
spective study. Patients were diagnosed on the basis of endos-
copy, computed tomography (CT), positron emission tomogra-
phy (PET), and pathologic examination. All patients were treat-
ed with radiotherapy combined with surgery or chemotherapy
for squamous cell carcinoma arising in the larynx, and were fol-
lowed regularly thereafter. Following suspicion of CRN, all pa-
tients underwent CT, PET, or combined PET/CT, and biopsy.
All necrotic tissues were removed with microforceps under sus-
pension laryngoscopy and sent for culture and pathologic exam-
ination to exclude recurrent cancer. Patients with recurrent tu-
mors were excluded from this study. The degree of CRN was
categorized according to the previously described grading sys-
tem for laryngeal radiation changes (3).
Each patient was treated with parenteral broad-spectrum antibi-
otics, humidity, and oral washing. HBO consisted of 2 hr of 2.5
atm 100% oxygen, once or twice daily, for 6 days each week.
If symptoms and signs became aggravated despite aggressive
therapy and were associated with other serious impending com-
plications, the patient underwent total laryngectomy. We revi-
ewed the diagnosis, treatment, and clinical course and outcome
of each patient.
RESULTS
Six patients (all men; mean age, 60 yr) were included in this
study; their clinical and treatment profiles are summarized in
Table 1. All patients previously had laryngeal cancer and were
treated with external beam radiotherapy (n=4) or intensity-
modulated radiotherapy (n=2), with a mean total radiation
dose to the larynx of 66.7±4.5 Gy. Three patients underwent
concurrent chemoradiotherapy. Two patients initially underwent
transoral laser microresection of laryngeal cancer and postoper-
ative radiotherapy for microscopic positive resection margins or
extensive nodal stage. The mean time between completion of
radiotherapy and CRN diagnosis was 8.8±4.1 months (range,
4 to 16 months). All patients complained of pain in the anterior
neck or odynophagia, and four patients had progressive dysp-
nea. All patients had a history of smoking (mean of 40±8 pack-
years; range, 29 to 50 pack-years), and two patients were smok-
ers at the time of CRN diagnosis. Two patients had chronic ob-
structive pulmonary disease, two had diabetes mellitus, and two
had hypertension. One patient underwent a laryngoscopic biop-
sy 1.5 months before diagnosis of CRN. All patients had Chandler
grade IV CRN.
CT revealed air bubbles, cartilage erosion or fragmentation,
fistula formation, or absence of the unilateral arytenoid cartilage
(Figs. 1, 2). All patients underwent PET or combined PET/CT
prior to suspension laryngoscopy and HBO. PET showed that
one patient had local tumor recurrence (false positive), and five
patients were free of tumors (true negatives). On suspension lar-
yngoscopy, all patients showed laryngeal mucosal erosion, as well
as fragmentation or sloughing of the exposed laryngeal cartilage:
three in the anterior larynx (Fig. 1) and three in the posterior
larynx (unilateral arytenoid and cricoid cartilages) (Fig. 2). All
patients underwent removal of necrotic tissue with microforceps.
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. Sex/ Tumor 
Initial
RT No. of Tumor
No Age and TNM
Tx
dose Time* Symptoms Signs Subsite Grade
� Tx HBO recur- Outcome
(yr) stage (Gy) Tx rence
Table 1. Summary of patients with chondroradionecrosis of the larynx
1 M/48 Supraglottic CCRT 70 4 Pain, odynophagia Erosion, slough, T, C IV AB, D, HBO 46 No Improved
T4aN2bM0 edema, fetor oris
2 M/63 Supraglottic CCRT 70.2 6 Pain, hoarseness, Erosion, slough, Ary (R), IV AB, D, HBO 32 No Improved
T3N0M0 dyspnea edema, fetor oris C
3 M/74 Supraglottic TLM+ND 59.4 8 Pain, odynophagia Erosion, slough Ary (R), IV AB, D, HBO 42 No Improved
T1N2bM0 RT C
4 M/59 Glottic TLM RT 67.5 9 Pain, hoarseness, Erosion, slough, Ary (R), IV AB, D, HBO, 30 No Improved
T2N0M0 dyspnea swelling C Tr
5 M/56 Glottic RT 63 10 Pain, dyspnea Erosion, slough, T, C IV AB, D, HBO, 36 No Improved
T1N0M0 edema, fetor oris Tr
6 M/58 Transglottic CCRT 70 16 Pain, dyspnea Erosion, fistula, T, C IV AB, D, HBO 32 No TL, PMMC
T4aN2bM0 edema, fetor oris
*Time (months) between diagnosis of laryngeal chondroradionecrosis anad completion of radiotherapy; 
� Chandler’s grading system for laryngeal radiation
changes (3).
AB: antibiotics; Ary: arytenoids; C: cricoid cartilage; CCRT: concurrent chemoradiotherapy; D: debridement; HBO: hyperbaric oxygen therapy; ND: neck
dissection; PMMC: pectoralis major myocutaneous flap transposition; R: right; RN: radionecrosis; RT: radiotherapy; T: thyroid cartilage; TL: total laryngecto-
my; TLM: transoral laser microresection; TNM: tumor-node-metastasis staging (AJCC 6th ed., 2002); Tr: tracheostomy; Tx: treatment.Pathologic examination of the tissue samples confirmed there
was no tumor recurrence.
All six patients were treated with antibiotics and HBO. Bac-
terial culture showed positive results in four patients, with infec-
tion by Streptococcus viridans, Enterobacter cloacae, Pseudo-
monas aeruginosa, or Acinetobacter baumannii. Antibiotic ther-
apy was dependent on the results of culture sensitivity tests. HBO
consisted of a mean of 36±6 dives (range, 32 to 46 dives). Alt-
hough respiratory distress improved in most patients after the
start of HBO, two patients received temporary tracheostomies to
resolve upper airway obstruction. Despite aggressive treatment,
one patient had aggravation of laryngeal CRN and infection of
the deep cervical space from a fistula. This patient underwent a
total laryngectomy and received coverage with transposition of
a pectoralis major myocutaneous flap. The other five patients
showed improvement of CRN on follow-up CT and endoscopy.
Pathologic examination of biopsy and laryngectomy specimens
showed no evidence of tumor recurrence in any of these patients.
Local recurrence of tumors or CRN was not observed during a
mean follow-up period of 24 months (range, 12 to 62 months).
One patient, however, died of regional recurrence and distant
metastasis.
DISCUSSION
Laryngeal CRN is a very rare but serious complication of radio-
therapy for laryngeal carcinoma, with an expected incidence of
less than 1% (8). Organ-preserving protocols have become more
popular in the treatment of patients with advanced laryngeal car-
cinomas. Combination radiotherapy and chemotherapy is increas-
ingly utilized; this may increase the incidence of complications
following radiotherapy. For example, of 341 patients with laryn-
geal or hypopharyngeal carcinomas treated with radiotherapy
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Fig. 1. Chondroradionecrosis of the anterior larynx after concurrent chemoradiotherapy (case no. 1). (A) Contrast-enhanced axial CT scan show-
ing an infiltrative mass in the anterior glottis and subglottis (asterisk). (B) CT scan 4 months after completion of radiotherapy showing air bubbles
around the thyroid cartilage in the glottis and subglottis (arrow). (C) Improvement of radionecrosis after early removal of necrotic tissue and HBO.
A B C
*
Fig. 2. Chondroradionecrosis of the posterior larynx after transoral laser microresection plus postoperative radiotherapy (case no. 3). (A) Lary-
ngoscopic photograph showing erosion and sloughing in the right posterior larynx (arrow). (B) Contrast-enhanced axial CT scan showing ero-
sion, air bubbles, and absence of the right arytenoid cartilage (arrow). (C) PET/CT scan showing hot uptake (maximum standardized uptake
value, 7.4) in the right arytenoid area (arrow), which was interpreted as tumor recurrence (false positive).
A B Calone or with chemoradiotherapy, 4 (1.2%) had CRN, and 8
(2.3%) had both CRN and tumor recurrence (9). The incidence
of CRN is directly related to the total dose, field size, and dura-
tion of therapy. The incidence increases at total doses of 70 Gy
or more (3). For example, of 18 patients with laryngeal CRN, 8
(44%) had been treated with total radiotherapy doses of 70 Gy
or more (7). Although the clinical presentation of CRN usually
occurs within one year after radiotherapy, it has been observed
more than 10 yr after radiotherapy (10, 11). Our study agrees
with these findings. In addition, our study is the first to report
two patients with CRN after they underwent the organ-preserv-
ing strategy of laser microsurgery plus radiotherapy. This sug-
gests that laryngeal subsites previously injured by laser surgery
may be more vulnerable to irradiation injury, resulting in carti-
lage exposure and necrosis.
Symptoms and signs of laryngeal complications from irradia-
tion vary from slight hoarseness, dryness, and edema to severe
pain, respiratory distress, fetor oris, and fistula formation (3).
Chandler grade (3) I or II laryngeal CRN is expected to occur in
patients after they have undergone irradiation; such cases gen-
erally do not require treatment. Chandler grade III and IV pa-
tients have serious complications and may progress despite ag-
gressive treatment measures. The symptoms and signs are simi-
lar to those seen in recurrent laryngeal carcinoma, presenting a
major diagnostic dilemma for clinicians (9, 12, 13). The CT ap-
pearance of laryngeal CRN is nonspecific and indistinguishable
from that of tumor recurrence. CRN, however, may be identifi-
able on CT through sloughing of the arytenoid cartilage, frag-
mentation and collapse of the thyroid cartilage, and/or the pres-
ence of gas bubbles around the cartilage (14). Although PET
may distinguish benign and malignant changes in the irradiated
larynx (15), repeated laryngoscopy and biopsy are essential to
help resolve this diagnostic problem. Even then, the answer may
not be clear because submucosal tumor recurrence may be detect-
ed on whole organ sections despite multiple biopsies (9, 12). To
differentiate CRN from tumor recurrence, a diagnostic algorithm
may be used, in which PET is initially performed in patients with
grade III or IV laryngeal complications, with biopsy subsequent-
ly performed in PET-positive patients (13). The follow-up PET
may also help to differentiate tumor recurrence and CRN occur-
rence by showing no change or a decrease in the standardized
uptake values of the focal uptakes (15). In the present study, one
of the six patients had false-positive PET results, and none had
local recurrence on pathologic examination or during follow-up.
Therefore, patients presenting with CRN after radiotherapy sh-
ould be under high suspicion for tumor recurrence.
Conservative measures have been recommended to treat pa-
tients with Chandler grade I or II CRN, including humidification,
steroids, and antibiotics for up to six weeks, Patients with grade
III or IV CRN are more difficult to treat, both medically and sur-
gically (8). The efficacy of HBO for laryngeal CRN was evaluat-
ed retrospectively in 18 patients; 13 (72%) showed functional
and symptomatic improvement, 4 failed to respond to treatment,
and 1 developed recurrence (7). The combination of HBO and
surgery led to improvement in 20 of 26 patients (77%) with ma-
ndibular osteoradionecrosis (5). In contrast, a recent randomized
controlled study showed that HBO did not benefit 68 patients
with overt mandibular osteoradionecrosis (16). Although the
rarity of CRN has precluded the use of randomized controlled
studies of HBO in the treatment of this condition, our findings
and the findings of others suggest that HBO may be effective in
treating CRN (6, 7). In addition, HBO may eliminate the need
for surgery and may enable patients who have had tracheosto-
mies to be decannulated (17). The present findings also suggest
that the early removal of necrotic tissue under suspension laryn-
goscopy may be helpful in the treatment of CRN, in combina-
tion with HBO. Radical surgery, such as total laryngectomy, may
sometimes be required to treat patients with progressive CRN,
nonfunctional larynges, and a high suspicion of tumor recurrence.
CRN of the larynx is a rare but fatal complication of radiother-
apy that may be detected early by endoscopic and imaging meth-
ods. Nevertheless, pathologic confirmation may be necessary to
exclude the possibility of tumor recurrence. Early removal of
necrotic tissue and HBO may help improve CRN and thereby
save the functional larynx.
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